| Product Code: ETC10765538 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In the Poland pemetrexed market, import trends showed a notable growth rate of 14.4% from 2023 to 2024, with a compound annual growth rate (CAGR) of 10.44% from 2020 to 2024. This upward import momentum can be attributed to increasing demand for pemetrexed-based pharmaceuticals in the region, reflecting a sustained market stability and potential for further growth in the pharmaceutical sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Pemetrexed Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Pemetrexed Market Revenues & Volume, 2022 & 2032F |
3.3 Poland Pemetrexed Market - Industry Life Cycle |
3.4 Poland Pemetrexed Market - Porter's Five Forces |
3.5 Poland Pemetrexed Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Poland Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Poland Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2022 & 2032F |
3.8 Poland Pemetrexed Market Revenues & Volume Share, By End User, 2022 & 2032F |
3.9 Poland Pemetrexed Market Revenues & Volume Share, By Administration Route, 2022 & 2032F |
4 Poland Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Poland Pemetrexed Market Trends |
6 Poland Pemetrexed Market, By Types |
6.1 Poland Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Poland Pemetrexed Market Revenues & Volume, By Indication, 2022 - 2032F |
6.1.3 Poland Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2022 - 2032F |
6.1.4 Poland Pemetrexed Market Revenues & Volume, By Mesothelioma, 2022 - 2032F |
6.1.5 Poland Pemetrexed Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.6 Poland Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.7 Poland Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.2 Poland Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Poland Pemetrexed Market Revenues & Volume, By Antifolate, 2022 - 2032F |
6.2.3 Poland Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2022 - 2032F |
6.2.4 Poland Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2022 - 2032F |
6.2.5 Poland Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2022 - 2032F |
6.2.6 Poland Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2022 - 2032F |
6.3 Poland Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Poland Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2022 - 2032F |
6.3.3 Poland Pemetrexed Market Revenues & Volume, By Immunotherapy, 2022 - 2032F |
6.3.4 Poland Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2022 - 2032F |
6.3.5 Poland Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2022 - 2032F |
6.3.6 Poland Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.4 Poland Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Poland Pemetrexed Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Poland Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2022 - 2032F |
6.4.4 Poland Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2022 - 2032F |
6.4.5 Poland Pemetrexed Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
6.4.6 Poland Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.5 Poland Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Poland Pemetrexed Market Revenues & Volume, By Intravenous, 2022 - 2032F |
6.5.3 Poland Pemetrexed Market Revenues & Volume, By Injection, 2022 - 2032F |
6.5.4 Poland Pemetrexed Market Revenues & Volume, By IV Infusion, 2022 - 2032F |
6.5.5 Poland Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2022 - 2032F |
6.5.6 Poland Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2022 - 2032F |
7 Poland Pemetrexed Market Import-Export Trade Statistics |
7.1 Poland Pemetrexed Market Export to Major Countries |
7.2 Poland Pemetrexed Market Imports from Major Countries |
8 Poland Pemetrexed Market Key Performance Indicators |
9 Poland Pemetrexed Market - Opportunity Assessment |
9.1 Poland Pemetrexed Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Poland Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Poland Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2022 & 2032F |
9.4 Poland Pemetrexed Market Opportunity Assessment, By End User, 2022 & 2032F |
9.5 Poland Pemetrexed Market Opportunity Assessment, By Administration Route, 2022 & 2032F |
10 Poland Pemetrexed Market - Competitive Landscape |
10.1 Poland Pemetrexed Market Revenue Share, By Companies, 2025 |
10.2 Poland Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here